hsa-mir-497-3p _LIHC.png
GRPEL2 _LIHC.png
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10004407
Fusion event
HBV-GRPEL2 integration
Validated
No
Detection method
HIVID
Data source
Curated
Sample type
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reported year
2016
PubMed ID
Virus Sequence
Virus name
HBV
Reference genome
AF090842.1;AB033554.1;AB014381.1;M32138.1;AB032431.1;AB036910.1;AB064310;AY090454.1
Host Sequence
Chromosome
chr5
Cytoband
q32
Reference genome
End
148733195/149353632 (Hg38)
Location type
UTR3
Target gene
miRNAs that regulate target gene
hsa-let-7b-5p ; hsa-mir-375 ; hsa-mir-30a-5p ; hsa-mir-21-5p ; hsa-mir-16-5p ; hsa-mir-615-3p ; hsa-let-7a-5p ; hsa-let-7c-5p ; hsa-let-7d-5p ; hsa-let-7e-5p ; hsa-let-7f-5p ; hsa-mir-98-5p ; hsa-mir-196a-5p ; hsa-let-7g-5p ; hsa-let-7i-5p ; hsa-mir-196b-5p ; hsa-mir-410-3p ; hsa-mir-1245a ; hsa-mir-4257 ; hsa-mir-4458 ; hsa-mir-4500 ; hsa-mir-6073 ; hsa-mir-6847-5p ; hsa-mir-8062 ; hsa-mir-8079 ; hsa-mir-4672 ; hsa-mir-17-5p ; hsa-mir-20a-5p ; hsa-mir-93-5p ; hsa-mir-106b-5p ; hsa-mir-20b-5p ; hsa-mir-519d-3p ; hsa-mir-4496 ; hsa-mir-95-5p ; hsa-mir-621 ; hsa-mir-3942-5p ; hsa-mir-4490 ; hsa-mir-4703-5p ; hsa-mir-4766-3p ; hsa-mir-580-5p ; hsa-mir-1257 ; hsa-mir-4697-3p ; hsa-mir-5579-3p ; hsa-mir-6882-5p ; hsa-mir-3125 ; hsa-mir-3916 ; hsa-mir-6859-5p ; hsa-mir-520g-5p ; hsa-mir-655-5p ; hsa-mir-1277-5p ; hsa-mir-5011-5p ; hsa-mir-595 ; hsa-mir-2116-5p ; hsa-mir-4255 ; hsa-mir-4677-5p ; hsa-mir-497-3p ; hsa-mir-519c-5p ; hsa-mir-519b-5p ; hsa-mir-523-5p ; hsa-mir-518f-5p ; hsa-mir-526a ; hsa-mir-520c-5p ; hsa-mir-518e-5p ; hsa-mir-518d-5p ; hsa-mir-522-5p ; hsa-mir-519a-5p ; hsa-mir-548d-3p ; hsa-mir-548h-3p ; hsa-mir-548t-3p ; hsa-mir-548z ; hsa-mir-548aa ; hsa-mir-548ac ; hsa-mir-548ap-3p ; hsa-mir-1295b-3p ; hsa-mir-548bb-3p ; hsa-mir-559 ; hsa-mir-548b-5p ; hsa-mir-548a-5p ; hsa-mir-548c-5p ; hsa-mir-548d-5p ; hsa-mir-548j-5p ; hsa-mir-548n ; hsa-mir-548h-5p ; hsa-mir-548i ; hsa-mir-548w ; hsa-mir-548y ; hsa-mir-548o-5p ; hsa-mir-548ab ; hsa-mir-548ad-5p ; hsa-mir-548ae-5p ; hsa-mir-548ak ; hsa-mir-548am-5p ; hsa-mir-548ap-5p ; hsa-mir-548aq-5p ; hsa-mir-548ar-5p ; hsa-mir-548as-5p ; hsa-mir-548au-5p ; hsa-mir-548ay-5p ; hsa-mir-548bb-5p ; hsa-mir-4792 ; hsa-mir-7158-5p ; hsa-mir-200b-5p ; hsa-mir-200a-5p ; hsa-mir-4517 ; hsa-mir-5680 ; hsa-mir-758-3p ; hsa-mir-1911-5p ; hsa-mir-624-5p ; hsa-mir-195-3p ; hsa-mir-16-2-3p ; hsa-mir-3908 ; hsa-mir-590-5p ; hsa-mir-224-5p ; hsa-mir-8485 ; hsa-mir-582-3p ; hsa-mir-4777-5p ; hsa-mir-466 ; hsa-mir-3941 ; hsa-mir-889-3p ; hsa-mir-4747-3p ; hsa-mir-4499 ; hsa-mir-6768-5p ; hsa-mir-22-5p ; hsa-mir-802 ; hsa-mir-4803
Nearest miRNA
hsa-mir-10397/Upstream/291223; hsa-mir-103a-1/Downstream/75286;
Nearest CpG islands
Upstream sequence
caatgacaaaaatggcaattactttcgcgccaTAATATTTCTCATGTGATCcacctggggggcattaagaaagataccgatgcactagcttcacctctgg
Downstream sequence
tcactatattgtccaggctagAAGAATTTTCTAATGGTCTATTACACCTCCCGTTTTGGCAAGTAAATTCAGAATAATTTTAGGTTCTTTTGTTATTCAG
Reference
Zhao, L. H., et al.Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma. Nat Commun ,2016,7: 12992.
Curate